Navacaprant did not statistically significantly improve MADRS total score or SHAPS total score compared with placebo. Topline data were announced from a phase 3 trial evaluating navacaprant for the ...
Patients with major depressive disorder, including those who have not responded to first-line antidepressants, may benefit from short-term nitrous oxide treatment, a major meta-analysis led by the ...
PsyPost on MSN
Short-acting psychedelic DMT shows promise as a rapid treatment for major depressive disorder
A recent study published in Nature Medicine suggests that a brief psychedelic experience combined with talk therapy can rapidly and safely reduce symptoms of severe depression. The findings indicate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results